52: A Single Dose of Gemtuzumab-Ozogamicin (GO) in Consolidation Prior to Autologous Transplant for Younger Patients with Newly Diagnosed Acute Myeloid (AML) is Safe But Has No Effect on Disease Free Survival: Interim Results of Eastern Cooperative Oncology Group Study (E1900)

✍ Scribed by H.F. Fernandez; Z. Sun; J.M. Bennett; E.M. Paietta; M.R. Litzow; J.M. Rowe; M.S. Tallman; H.M. Lazarus

• Book ID: 116279880
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 90 KB
• Volume: 14
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2007.12.060